Inhibrx Biosciences, Inc. (INBX)
84.52
+4.24
(+5.28%)
USD |
NASDAQ |
Nov 06, 16:00
84.95
+0.43
(+0.51%)
After-Hours: 20:00
Inhibrx Biosciences Price : 84.52 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 80.68 | 85.58 | 79.47 | 84.52 | 220249.0 |
| Nov 05, 2026 | 86.00 | 86.81 | 79.35 | 80.28 | 242328.0 |
| Nov 04, 2026 | 83.95 | 87.13 | 82.03 | 86.76 | 190215.0 |
| Nov 03, 2026 | 71.16 | 83.00 | 71.16 | 81.08 | 600239.0 |
| Nov 02, 2026 | 72.45 | 73.49 | 70.87 | 72.16 | 234383.0 |
| Oct 30, 2026 | 72.04 | 73.03 | 66.80 | 71.78 | 438828.0 |
| Oct 29, 2026 | 73.75 | 75.72 | 71.75 | 73.65 | 358741.0 |
| Oct 28, 2026 | 94.55 | 96.78 | 69.27 | 73.29 | 1.189M |
| Oct 27, 2026 | 88.52 | 99.88 | 88.52 | 95.66 | 374216.0 |
| Oct 26, 2026 | 93.80 | 94.46 | 86.92 | 88.61 | 251184.0 |
| Oct 23, 2026 | 96.96 | 96.99 | 92.50 | 93.38 | 176221.0 |
| Oct 22, 2026 | 96.94 | 100.20 | 94.04 | 97.10 | 249511.0 |
| Oct 21, 2026 | 98.10 | 99.82 | 93.00 | 98.19 | 239320.0 |
| Oct 20, 2026 | 89.07 | 96.50 | 88.99 | 95.30 | 221432.0 |
| Oct 19, 2026 | 90.43 | 92.98 | 88.21 | 89.79 | 156062.0 |
| Oct 16, 2026 | 89.83 | 90.72 | 87.72 | 89.83 | 146452.0 |
| Oct 15, 2026 | 87.60 | 91.68 | 87.20 | 90.50 | 226452.0 |
| Oct 14, 2026 | 86.23 | 87.36 | 83.61 | 85.26 | 246809.0 |
| Oct 13, 2026 | 90.11 | 92.46 | 85.80 | 87.08 | 271318.0 |
| Oct 12, 2026 | 94.03 | 96.10 | 90.00 | 90.53 | 216103.0 |
| Oct 09, 2026 | 92.70 | 95.81 | 92.70 | 95.01 | 86819.00 |
| Oct 08, 2026 | 93.14 | 93.28 | 90.15 | 92.76 | 208039.0 |
| Oct 07, 2026 | 92.02 | 96.71 | 90.66 | 93.36 | 223780.0 |
| Oct 06, 2026 | 95.52 | 96.96 | 92.60 | 93.41 | 169451.0 |
| Oct 05, 2026 | 97.56 | 98.51 | 94.18 | 94.56 | 207091.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.15 |
| Amgen, Inc. | 460.42 |
| Anika Therapeutics, Inc. | 14.55 |
| BioCryst Pharmaceuticals, Inc. | 7.69 |
| Imunon, Inc. | 0.8448 |
Price Related Metrics
| Earnings Yield | -10.50% |
| Market Cap | 1.243B |